These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23199653)

  • 1. Geographical distribution of lymph node metastases on MR lymphography in prostate cancer patients.
    Meijer HJ; Fortuin AS; van Lin EN; Debats OA; Alfred Witjes J; Kaanders JH; Barentsz JO
    Radiother Oncol; 2013 Jan; 106(1):59-63. PubMed ID: 23199653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High occurrence of aberrant lymph node spread on magnetic resonance lymphography in prostate cancer patients with a biochemical recurrence after radical prostatectomy.
    Meijer HJ; van Lin EN; Debats OA; Witjes JA; Span PN; Kaanders JH; Barentsz JO
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1405-10. PubMed ID: 21640507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance lymphography findings in patients with biochemical recurrence after prostatectomy and the relation with the Stephenson nomogram.
    Meijer HJ; Debats OA; Roach M; Span PN; Witjes JA; Kaanders JH; van Lin EN; Barentsz JO
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1186-91. PubMed ID: 22520482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of PET/CT and MR lymphography in treatment of prostate cancer patients with lymph node metastases.
    Fortuin AS; Deserno WM; Meijer HJ; Jager GJ; Takahashi S; Debats OA; Reske SN; Schick C; Krause BJ; van Oort I; Witjes AJ; Hoogeveen YL; van Lin EN; Barentsz JO
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):712-8. PubMed ID: 22417806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU).
    Sargos P; Guerif S; Latorzeff I; Hennequin C; Pommier P; Lagrange JL; Créhange G; Chapet O; de Crevoisier R; Azria D; Supiot S; Habibian M; Soulié M; Richaud P
    Cancer Treat Rev; 2015 Dec; 41(10):814-20. PubMed ID: 26508669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition.
    Ganswindt U; Paulsen F; Corvin S; Eichhorn K; Glocker S; Hundt I; Birkner M; Alber M; Anastasiadis A; Stenzl A; Bares R; Budach W; Bamberg M; Belka C
    BMC Cancer; 2005 Jul; 5():91. PubMed ID: 16048656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance lymphography-guided selective high-dose lymph node irradiation in prostate cancer.
    Meijer HJ; Debats OA; Kunze-Busch M; van Kollenburg P; Leer JW; Witjes JA; Kaanders JH; Barentsz JO; van Lin EN
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):175-83. PubMed ID: 21075555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of prostate nodes: a PET/CT-derived anatomic atlas of prostate cancer patients before and after surgical treatment.
    Hegemann NS; Wenter V; Spath S; Kusumo N; Li M; Bartenstein P; Fendler WP; Stief C; Belka C; Ganswindt U
    Radiat Oncol; 2016 Mar; 11():37. PubMed ID: 26968955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pelvic lymph node topography for radiotherapy treatment planning from ferumoxtran-10 contrast-enhanced magnetic resonance imaging.
    Dinniwell R; Chan P; Czarnota G; Haider MA; Jhaveri K; Jewett M; Fyles A; Jaffray D; Milosevic M
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):844-51. PubMed ID: 19095369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferumoxtran-10 MR lymphography for target definition and follow-up in a patient undergoing image-guided, dose-escalated radiotherapy of lymph nodes upon PSA relapse.
    Weidner AM; van Lin EN; Dinter DJ; Rozema T; Schoenberg SO; Wenz F; Barentsz JO; Lohr F
    Strahlenther Onkol; 2011 Mar; 187(3):206-12. PubMed ID: 21347637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized coverage of high-risk adjuvant lymph node areas in prostate cancer using a sentinel node-based, intensity-modulated radiation therapy technique.
    Ganswindt U; Paulsen F; Corvin S; Hundt I; Alber M; Frey B; Stenzl A; Bares R; Bamberg M; Belka C
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):347-55. PubMed ID: 17236960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy.
    Myrehaug S; Chan G; Craig T; Weinberg V; Cheng C; Roach M; Cheung P; Sahgal A
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e657-62. PubMed ID: 22245189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphatic spread of nodal metastases in high-risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum.
    Briganti A; Suardi N; Capogrosso P; Passoni N; Freschi M; di Trapani E; Gallina A; Capitanio U; Abdollah F; Tutolo M; Bianchi M; Salonia A; Da Pozzo LF; Montorsi F; Rigatti P
    Prostate; 2012 Feb; 72(2):186-92. PubMed ID: 21538428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of lymph node positivity on
    McClinton C; Niroumand M; Sood S; Shah V; Hill J; Dusing RW; Shen X
    Pract Radiat Oncol; 2017; 7(5):325-331. PubMed ID: 28377141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective analysis of the prognosis of prostate cancer patients with lymph node involvement on MR lymphography: who might be cured.
    Meijer HJ; Debats OA; van Lin EN; Witjes JA; Kaanders JH; Barentsz JO
    Radiat Oncol; 2013 Jul; 8():190. PubMed ID: 23898991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of MR lymphography for the detection of lymph node metastases in patients with prostate cancer.
    Hövels AM; Heesakkers RA; Adang EM; Barentsz JO; Jager GJ; Severens JL
    Radiology; 2009 Sep; 252(3):729-36. PubMed ID: 19717752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping of nodal disease in locally advanced prostate cancer: rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy.
    Shih HA; Harisinghani M; Zietman AL; Wolfgang JA; Saksena M; Weissleder R
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1262-9. PubMed ID: 16253781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer.
    Fonteyne V; De Gersem W; De Neve W; Jacobs F; Lumen N; Vandecasteele K; Villeirs G; De Meerleer G
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1013-20. PubMed ID: 19386427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphatic drainage and CTV in carcinoma of the prostate.
    Cellini N; Luzi S; Mantini G; Mattiucci GC; Morganti AG; Digesù C; Bavasso A; Deodato F; Smaniotto D; Valentini V
    Rays; 2003; 28(3):337-41. PubMed ID: 15018322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic lymph node dissection for prostate cancer: frequency and distribution of nodal metastases in a contemporary radical prostatectomy series.
    Godoy G; von Bodman C; Chade DC; Dillioglugil O; Eastham JA; Fine SW; Scardino PT; Laudone VP
    J Urol; 2012 Jun; 187(6):2082-6. PubMed ID: 22498221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.